Back to 
Susquehanna International Group, LLP
Susquehanna International Group, LLP
HCWB
2 quarters
Position history for Susquehanna International Group, LLP's holdings in HCW Biologics Inc.
No. Susquehanna International Group exited its HCWB (HCW Biologics) position in Q1 2026. Its Q4 2025 13F listed 20,071 shares worth $19,481. Susquehanna International Group first reported HCWB in Q4 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$19,481
Total Shares Change
-20,071
Quarter-by-Quarter History
Other major holders of HCWB: HRT Financial LP, Vanguard Group Inc., Geode Capital Management, LLC, UBS Group AG, Citadel Advisors LLC